Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Rosaria De Filippi"'
Publikováno v:
Infectious Agents and Cancer, Vol 19, Iss 1, Pp 1-4 (2024)
Abstract Despite the global vaccination campaigns, certain patient groups remain highly vulnerable to SARS-CoV-2 and are at high risk for unfavorable COVID-19 outcomes. As previously shown by our group and a more recent report by Chang Su and coworke
Externí odkaz:
https://doaj.org/article/8a02b22926f4416e90d81424a8c846d0
Autor:
Domenico Mallardo, Mario Fordellone, Andrew White, Jakob Vowinckel, Michael Bailey, Francesca Sparano, Antonio Sorrentino, Mario Mallardo, Bianca Arianna Facchini, Rosaria De Filippi, Gerardo Ferrara, Vito Vanella, Kristina Beeler, Paolo Chiodini, Alessandra Cesano, Sarah Warren, Paolo A. Ascierto
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 17, p 9345 (2024)
Resistance biomarkers are needed to identify patients with advanced melanoma obtaining a response to ICI treatment and developing resistance later. We searched a combination of molecular signatures of response to ICIs in patients with metastatic mela
Externí odkaz:
https://doaj.org/article/c2ee6e498f014e2b90466676f1a10833
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 14, p 7509 (2024)
Dendritic cell (DC) cancer vaccines are a promising therapeutic approach, leveraging the immune system to fight tumors. These vaccines utilize DCs’ ability to present tumor-associated antigens to T cells, triggering a robust immune response. DC vac
Externí odkaz:
https://doaj.org/article/98f9abfe23704a199e5737d03dc814ea
Autor:
Domenico Galati, Serena Zanotta, Mariaelena Capone, Gabriele Madonna, Domenico Mallardo, Marilena Romanelli, Ester Simeone, Lucia Festino, Francesca Sparano, Rosa Azzaro, Rosaria De Filippi, Antonio Pinto, Chrystal M. Paulos, Paolo A. Ascierto
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Background Nivolumab is an anti-PD1 antibody that has dramatically improved metastatic melanoma patients’ outcomes. Nevertheless, many patients are resistant to PD-1 inhibition, occasionally experiencing severe off-target immune toxicity.
Externí odkaz:
https://doaj.org/article/fc778616ad9c4244b22051d8743c7e29
Autor:
Gianpaolo Marcacci, Nicola Coppola, Emanuela Madonna, Cristina Becchimanzi, Stefania De Pascalis, Silvia D’Ovidio, Stefania Crisci, Piera Maiolino, Rosaria De Filippi, Antonio Pinto
Publikováno v:
Infectious Agents and Cancer, Vol 17, Iss 1, Pp 1-7 (2022)
Abstract Background To date, there is no information on the safety and efficacy of the novel anti-sarbecoviruses monoclonal antibody sotrovimab administered, as a post-exposure prophylactic measure, during the aplastic phase of autologous stem cell t
Externí odkaz:
https://doaj.org/article/cd5de9fa28e448ed9273f321154ab676
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 3, p 1454 (2024)
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic cancer originating from the malignant transformation of plasmacytoid dendritic cell precursors. This malignancy progresses rapidly, with frequent relapses and a
Externí odkaz:
https://doaj.org/article/b580df0c10db43cf8c9b1d19502d54e7
Autor:
Rosaria De Filippi, Fortunato Morabito, Armando Santoro, Giovanni Tripepi, Francesco D’Alò, Luigi Rigacci, Francesca Ricci, Emanuela Morelli, Pier Luigi Zinzani, Antonio Pinto
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-10 (2021)
Abstract Background Overweight and obese patients with solid tumors receiving anti-programmed cell death-1 (PD-1)/PD-ligand-1(PD-L1) immune checkpoint inhibitors exhibit improved survival and higher risk of immune-related adverse events (irAEs) than
Externí odkaz:
https://doaj.org/article/f8e8de9a4961465ba54ef26969155fce
Autor:
Gianpaolo Marcacci, Giuseppe Fiorentino, Francesco Volzone, Umberto Falcone, Roberto Parrella, Daniela Donnarumma, Silvia D’Ovidio, Anna Annunziata, Giovanni Micallo, Giuseppe Portella, Annarosaria De Chiara, Rosaria De Filippi, Stefania Crisci, Antonio Pinto
Publikováno v:
Infectious Agents and Cancer, Vol 16, Iss 1, Pp 1-6 (2021)
Abstract Patients with non-hodgkin lymphomas (NHL) represent a population of special interest during the current Coronavirus disease-19 (COVID-19) pandemics. NHLs are associated with disease- and treatment-related immunodeficiencies which may generat
Externí odkaz:
https://doaj.org/article/30f5ce1a2b734cd8a426fabc6ab593e7
Autor:
Stefania Crisci, Raffaele Di Francia, Sara Mele, Pasquale Vitale, Giuseppina Ronga, Rosaria De Filippi, Massimiliano Berretta, Paola Rossi, Antonio Pinto
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
The improved knowledge of pathogenetic mechanisms underlying lymphomagenesis and the discovery of the critical role of tumor microenvironments have enabled the design of new drugs against cell targets and pathways. The Food and Drug Administration (F
Externí odkaz:
https://doaj.org/article/b2737f788f204fcf90cd34a82513151b
Autor:
Stefania Crisci, Concetta Meo, Sara Mele, Giancarla Iaccarino, Antonio Pinto, Rosaria De Filippi, Elvira Pota, Irene Postiglione
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:e660-e666